Arş. Gör. ERGİ KAYA

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Feasibility of exergaming for upper extremity rehabilitation in people with multiple sclerosis: prospective clinical trial.

Ozdogar A. T., Emec M., Kaya E., Karakas H., Dastan S., Kahraman T., et al.

Acta neurologica Belgica , 2024 (SCI-Expanded)

COVID-19 vaccine response in Neuromyelitis Optica Spectrum Disorder.

Baba C., Kaya E., Ozcelik S., Ozdogar A. T., Samedzade U., Cevik S., et al.

Clinical neurology and neurosurgery , cilt.238, sa.238, ss.108152, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

Factors related to restless leg syndrome in neuromyelitis optica spectrum disorder

Ozdogar A. T., KAYA E., Sagici O., Dastan S., Karakas H., Baba C., et al.

MULTIPLE SCLEROSIS JOURNAL , cilt.28, sa.3_SUPPL, ss.1008, 2022 (SCI-Expanded)

Relationship between presence of spinal cord lesion and restless legs syndrome in multiple sclerosis

Baba C., Ozdogar A. T., ÖZÇELİK S., KAYA E., ÖZAKBAŞ S.

SOMATOSENSORY AND MOTOR RESEARCH , sa.2-4, ss.116-120, 2022 (SCI-Expanded)

Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies.

Baba C., Ozcelik S., Kaya E., Samedzada U., Ozdogar A. T., Cevik S., et al.

Multiple sclerosis and related disorders , cilt.68, ss.104119, 2022 (SCI-Expanded)

Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies

Özakbaş S., Baba C., Doğan Y., Cevik S., Özçelik S., Kaya E.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.58, 2022 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

Rat siyatik sinirine 120 ve 240 saniye olarak uygulanan devamlı ve pulsed radyofrekansın etkileri

Özkumur G., Kırımlıoğlu E., Kaya E., Demir N., Yeğin M. A.

AGRI DERGISI , cilt.36, sa.1, ss.1-12, 2024 (ESCI)

Can 900 MHz and 2100 MHz radiofrequency radiation exposure induce endoplasmic reticulum stress and apoptosis in rat thymus?

Kaya E., Kirimlioglu E., ER H., OKAN A., ÖZEN Ş., Demir N.

The European Research Journal , cilt.9, sa.1, ss.29-38, 2023 (Hakemli Dergi)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

ÇOK DİL BİLEN AFAZİK HASTADA TPA TEDAVİSİ

Calayır F., Çiftçi L., Kaya E., Öztürk V.

International 7th Stroke Academy of Turkey and Practical Courses, Aydın, Türkiye, 2 - 05 Kasım 2023, cilt.29, ss.120

Serum progranulin levels and cognitive function in people with multiple sclerosis: limited evidence for an association

KAYA E., Cevik S., Sagici O., ÖZÇELİK S., DOĞAN Y., Ozakbas S.

9th Joint ECTRIMS-ACTRIMS meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.902-903

A comparison of cognitive batteries to assess cognitive impairment in multiple sclerosis

Yiğit P., Sağıcı Ö., Özçelik S., Abasıyanık Z., Kaya E., Baba C., et al.

The 9th Joint ECTRIMS-ACTRIMS Meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.102

Efficacy of Original Fingolimod vs. Generic-Brand Drugs in Treating Multiple Sclerosis: A comparative Study Using Real-World Data from Turkey

Özçelik S., Sağıcı Ö., Özdoğar A. T., Kaya E., Özakbaş S.

The 9th Joint ECTRIMS-ACTRIMS Meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.292-293

Comparison of early-onset and very early-onset people with multiple sclerosis based on cognitive and physical assessments

Kaya E., Özdoğar A. T., Karakaş H., Sağıcı Ö., Özakbaş S.

The 9th Joint ECTRIMS-ACTRIMS Meeting, Milan, İtalya, 11 - 13 Ekim 2023, ss.698

İntravenöz trombolitik tedavi sonrası gelişen subaraknoid kanama olgusu

CALAYIR F., KAYA E., MEN S., YAKA E.

58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 Kasım 2022

Effects of ocrelizumab on disability progression and inflammatory activity in multiple sclerosis patients during the two-year follow-up

Özakbaş S., Baba C., Kaya E., Özçelik S., Özdoğar A. T., Daştan S.

ECTRIMS 2022, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, sa.1084, ss.862

Real-world data of ocrelizumab effects on disability progression; A 2-year follow-up study

Baba C., Kaya E., Özçelik S., Özdoğar A. T., Sağıcı Ö., Daştan S., et al.

ECTRIMS 2022, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, sa.821, ss.860

Physical and cognitive profile of elderly persons with multiple sclerosis and comparison with healthy controls

Özakbaş S., Özdoğar A. T., Baba C., Özçelik S., Kaya E., Sağıcı Ö.

ECTRIMS 2022, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, sa.821, ss.705

Cognitive functions in persons with multiple sclerosis treated with fingolimod: 2-years follow-up study

Özakbaş S., Yiğit P., Baba C., Kaya E., Sağıcı Ö., Özçelik S., et al.

ECTRIMS 2022, Amsterdam, Hollanda, 26 - 28 Ekim 2022, cilt.28, sa.359, ss.378

COVID-19 antibody response after two doses of SARS-CoV-2 vaccines in multiple sclerosis patients; an update to the previous study

Ozakbas S., Baba C., ÖZÇELİK S., Özdoğar A. T., KAYA E., DOĞAN Y., et al.

38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, sa.922, ss.764-765

Immune response against SARS-CoV-2 vaccines in treatment-naive multiple sclerosis patients

Ozakbas S., Baba C., SAMADZADE U., KAYA E., ÖZÇELİK S., Özdoğar A. T., et al.

38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, sa.941, ss.776

BOS OLİGOKLONAL BANT ANALİZİNDE “AYNA PATERNİ” VARLIĞI AYIRICI TANIDA BİR İPUCU OLABİLİR Mİ?

Gözgöz H., Kaya E., Kutlu A., Özakbaş S., Akan P.

XXII. Ulusal Klinik Biyokimya Kongresi, Antalya, Türkiye, 12 - 15 Mayıs 2022, ss.227

Comparison of late-onset and early-onset people with multiple sclerosis based on cognitive and physical assessments

Özakbaş S., Kaya E., Özdoğar A. T.

8th European Academy of Neurology Congress, Vienna, Avusturya, 25 - 28 Haziran 2022, ss.640

Early treatment response of ocrelizumab in persons with multiple sclerosis: six-month results

Özakbaş S., Özçelik S., Kaya E., Özdoğar A. T., Sağıcı Ö., Baba C.

ECTRIMS, Vienna, Avusturya, 13 - 15 Kasım 2021, ss.278

Relationship between presence of spinal cord lesion and restless legs syndrome in multiple sclerosis

Özakbaş S., Özdoğar A. T., Baba C., Özçelik S., Kaya E.

ECTRIMS, Vienna, Avusturya, 13 - 15 Kasım 2021, ss.259

Comparison of early treatment response of ocrelizumab in relapsing and progressive multiple sclerosis patients on the basis of cognitive functions

Özakbaş S., Özçelik S., Kaya E., Özdoğar A. T., Sağıcı Ö., Baba C.

ECTRIMS, Vienna, Avusturya, 13 - 15 Kasım 2021, ss.276

Metrikler

Yayın

Atıf (WoS)

H-İndeks (WoS)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler